TransCode Therapeutics, Inc. (RNAZ) — 分析師展望 / 分析師共識目標價為. 基於 1 位分析師評級, 共識為 看漲 — 1 買入.
分析師預估 每股收益(EPS)為 $-4,398.24 和 營收為 $0.00B (下一財年).
每股收益(EPS)歷史表現: 2024: 實際 $-47.14 vs 預期 $-4,398.24 (超預期 +98.9%). 分析師準確度: 0%.
RNAZ 分析師評級
Buy
基於過去3個月內 1 位分析師對 TransCode Therapeutics, Inc. 的評級
EPS 預測 — RNAZ
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$47.14
vs Est –$4,398.24
▲ 9,230.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
營收預測 — RNAZ
Revenue Trend
Analysts expect stable revenue going forward.
